作者
Jessica J Bartoszko, Reed AC Siemieniuk, Elena Kum, Anila Qasim, Dena Zeraatkar, Juan Pablo Diaz Martinez, Maria Azab, Sara Ibrahim, Ariel Izcovich, Gonzalo Bravo Soto, Yetiani Roldan, Arnav Agarwal, Thomas Agoritsas, Derek K Chu, Rachel Couban, Tahira Devji, Farid Foroutan, Maryam Ghadimi, Kimia Honarmand, Assem Khamis, Francois Lamontagne, Mark Loeb, Shelley L McLeod, Sharhzad Motaghi, Srinivas Murthy, Reem A Mustafa, Bram Rochwerg, Charlotte Switzer, Lehana Thabane, Per O Vandvik, Robin WM Vernooij, Ying Wang, Liang Yao, Gordon H Guyatt, Romina Brignardello-Petersen
发表日期
2021/4/26
来源
Bmj
卷号
373
出版商
British Medical Journal Publishing Group
简介
Updates
This is the second version (first update) of the living systematic review, replacing the previous version (available as a data supplement). When citing this paper please consider adding the version number and date of access for clarity.
Objective
To determine and compare the effects of drug prophylaxis on severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (covid-19).
Design
Living systematic review and network meta-analysis (NMA).
Data sources
WHO covid-19 database, a comprehensive multilingual source of global covid-19 literature to 4 March 2022.
Study selection
Randomised trials in which people at risk of covid-19 were allocated to prophylaxis or no prophylaxis (standard care or placebo). Pairs of reviewers independently screened potentially eligible articles.
Methods
After duplicate data abstraction, we conducted random-effects bayesian …
学术搜索中的文章
JJ Bartoszko, RAC Siemieniuk, E Kum, A Qasim… - Bmj, 2021